They can improve adult ADHD symptoms to a certain extent according to the randomized controlled phase II clinical trials [47–49], indicating the feasibility of using gastrodin to treat ADHD by increasing CHRNA3 expression. This evidence concerns the gene CHRNA3 and attention deficit-hyperactivity disorder.